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Continuous positive airway pressure (CPAP) refers to the application of continuous pressure during both inspiration and expiration in a spontaneously breathing baby. CPAP 
helps in opening of atelectatic alveoli, splints the airways, reduces 
work of breathing, and improves the pattern and regularity of 
respiration. Atelectotrauma, biotrauma, and volutrauma, the key 
determinants of ventilation-induced lung injury are minimal or 
absent with this mode of ventilation [1].
Underwater bubble CPAP remains in use since first devised in 
the early 1970s [2]. With this technique, gas flows past the nasal 
device and the pressure is generated in the circuit by placing the 
distal limb of the CPAP circuit under a known depth of water. 
This is a simple and effective technique which can be applied 
with inexpensive equipment. A unique feature is that the loss of 
CPAP pressure is detectable by the disappearance of the bubbling.
Apart from pressure, bubble CPAP produces oscillations of 
up to 4 cm H2O due to bubbling of water in the bubble chamber. 
These oscillations act like high-frequency ventilation and may 
help in gas exchange. It has been suggested that bubble CPAP is 
more effective than ventilator CPAP due to these oscillations [3]. 
Bubble CPAP, when used appropriately, is more cost effective, 
less intensive, requires less training, and has lower risk of 
complications. It is a less expensive method of respiratory 
support, most suitable to neonatal units with limited resources in 
developing countries [4]. The present study was undertaken to 
assess the effectiveness of bubble CPAP for premature neonates 
with respiratory distress syndrome (RDS) treated in a tertiary care 
public sector teaching hospital.
MATERIALS AND METHODS
This prospective observational study was conducted in special 
newborn care unit in Mahatma Gandhi Memorial Hospital, 
Kakatiya Medical College, Warangal, from January 2016 to 
November 2017. A total of 243 preterm neonates with gestational 
age (GA) between 28 and <37 weeks with respiratory distress 
(Silverman Anderson Score [SAS] ≥3 in GA <35 weeks and 
≥5 in GA >35 weeks) and chest X-ray suggestive of RDS 
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were included in this study. Neonates with GA <28 weeks and 
≥37 weeks, neonates with no spontaneous respiration at birth, and 
neonates with congenital anomalies such as cleft lip, cleft palate, 
tracheoesophageal fistula, congenital diaphragmatic hernia, and 
choanal atresia were excluded from the study. The Institutional 
Ethical Committee approval was taken before starting the study 
and parental consent was taken before recruiting the cases.
All the eligible preterm neonates were started on bubble CPAP 
(Fischer and Paykel) with binasal prongs (Hudson prongs). CPAP 
was started at 5 cm of water and adjusted to minimize the chest 
retractions. FiO2 was adjusted to maintain SpO2 90–94%. Flow 
of gas was started at 5 L/min and was adjusted until continuous 
bubbling was noted in the chamber. Surfactant was administered 
by intubation-surfactant-extubation method for babies with 
moderate-to-severe RDS on the chest X-ray showing extensive 
reticulonodular pattern or complete white-out lung fields.
Preterm neonates with minimal or no chest retractions, having 
a respiratory rate between 40 and 60/min and normal saturation on 
FiO2 <30% and positive end-expiratory pressure (PEEP) <5 cm 
of water, were weaned off from bubble CPAP. Bubble CPAP was 
considered to be efficacious if the respiratory distress improved 
and baby could be successfully weaned off from CPAP. (Baby 
remains off CPAP for the next 72 h). CPAP failure was defined as 
the need for mechanical ventilation when they remained hypoxic, 
i.e., SpO2 <87% despite FiO2 >60%, PEEP >7 cm of water or had 
severe retractions on PEEP >7 cm of water or had recurrent apneas.
Maternal, perinatal, and neonatal data were collected in a 
predesigned pro forma. GA was calculated based on the mother’s 
last menstrual period or expanded new Ballard score. Based on the 
radiological findings, severity of RDS was graded as mild – mild 
granulations of lungs, moderate – generalized granularity of 
lung with air bronchogram with preserved cardiac borders, and 
severe – whiteout lungs with loss of cardiac borders.
Appropriate statistical tests were applied using software SPSS 
version 21. Baseline variables were compared between those 
who could be successfully weaned from CPAP (CPAP-success 
group) and those who failed (CPAP-failure group). Mean and 
standard deviation was calculated for continuous variables and 
percentages were calculated for categorical variables. Univariate 
analysis was done to study factors responsible for the failure of 
CPAP using Student’s t-test or Chi-square test or Fisher’s exact 
test as appropriate depending on the variable.
RESULTS
A total of 243 preterm neonates were enrolled in the study with 
a mean GA of 32.4 weeks and mean birth weight of 1831.49 g. 
Out of these, 151 (62.13%) neonates were male. Among the 
study population, 25 mothers had preterm premature rupture of 
membranes. In this study, 167 (68.72%) were cesarean deliveries 
and 8 (3.29%) neonates received antenatal steroids. The above 
results are summarized in Table 1.
Among 243 neonates, 195 (80.2%) were successfully weaned 
off from CPAP and 48 (19.8%) failed CPAP. The mean birth 
weight in the CPAP-success group was 2088.71±484.08 g and 
the CPAP-failure group was 1574.27±596.10 g. The mean GA in 
CPAP success was significantly higher (33.49±2.24 weeks) than 
in the CPAP-failure group (31.31±2.78 weeks). The mean age at 
the beginning of CPAP was lower in success than in the failure 
group (12.39±11.52 h vs. 14.5±13.38 h). The mean duration of 
CPAP in the success group was 62.73±30.51 h and in the CPAP 
failure group was 47.56±53.54 h.
Comparison of maternal and neonatal variables between 
successful and failure groups is shown in Table 2. It was found 
that lower GA (mean <31 weeks) birth weight <1.5 kg, SAS ≥7, 
severe RDS on chest X-ray, and presence of sepsis were associated 
with CPAP failure. Table 3 shows the number of cases in CPAP 
success and failure groups in relation to the time of initiation 
of CPAP. Out of 243 babies, only 22 babies received surfactant 
along with CPAP, as shown in Table 3.
A total of 216 (88.88%) received CPAP alone; out of them, 
195 (90.27%) survived and 21 (9.7%) babies expired. Out of 
243 babies, 27 (11.11%) babies were kept on ventilation due 
to CPAP failure. Among 27 ventilated babies, 20 (74.07%) 
survived and 7 (25.9%) babies died. The most common 
complication seen in babies put on CPAP was sepsis (66, 27.1%) 
followed by nasal trauma (45, 18.1%) and shock (3, 1.23%). 
Periventricular leukomalacia was seen in 2 (0.82%) cases while 
intraventricular hemorrhage and pneumothorax were seen in 
1 (0.41%) neonate each.
DISCUSSION
In our study, 80% of neonates were successfully weaned off from 
the CPAP and these results were higher than those observed by 
Koti et al. [1] and Urs et al. [5]. In the present study, 38.3% of 
the study population were of 32–34 weeks gestation and another 
38.3% of population was of 35–37 weeks gestation. About 50.6% 
of population was of weight ˃2000 g, 19.7% were <1500 g, and 
4.1% were <1000 g neonates. Urs et al. included neonates of GA 
28 to ˂37 weeks (n=50), and 76% of them were of 32–34 weeks 
Table 1: Basic demographic features of the study
Variable Groups Number (%)
Gestational age (weeks) 28–31 57 (23.45)
32–34 93 (38.27)
35–<37 93 (38.27)
Birth weight (g) ≤1000 16 (6.58)
1001–1500 42 (17.28)
1501–2000 62 (25.51)
>2000 123 (50.61)
Gender Male 151 (62.13)
Female 92 (37.86)
Maternal condition PPROM 25 (10.28)
PIH 19 (7.81)
Type of delivery Cesarean delivery 167 (68.72)
Antenatal steroid Yes 8 (3.29)
PPROM: Preterm premature rupture of membranes, PIH: Pregnancy‑induced 
hypertension
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gestation, 66% had birth weight <1500 g, and 8% <1000 g [5]. 
In a study by Koti et al., the study population (n=56) consisted 
of neonates of GA 28–34 weeks, including 55.3% very low birth 
weight (VLBW) and 17.9% ELBW neonates. More success rate 
in the present study compared to these studies may be attributed 
to larger total sample size with a major portion belonging to 
neonates with later GA and birth weight ˃2000 g.
Sandri et al. have shown higher need for respiratory assistance 
in male neonates with RDS. Similar to the study by Urs et al., 
outcome of bubble CPAP did not vary between genders in this 
study [6]. Statistically significant CPAP success was seen in 
neonates born to mothers who had received antenatal steroids in 
a study by Urs et al. (p˂0.001) and Koti et al. (p<0.02). Success 
was higher in neonates who were given antenatal steroids; 
however, no such significance was found in studies by Sethi et al. 
and Shamil et al. [7,8]. In our study, the percentage of neonates 
who received antenatal steroids (3.2%) was lower in comparison 
to other similar studies.
In this study, the mean age at initiation of CPAP was 13.44 h of 
life, which was higher than that observed in a study by Urs et al. 
(5.5 h). This could be due to delayed presentation of the neonates 
to this hospital thus delaying the treatment. Cochrane systematic 
review concluded that the application of CPAP early in the course 
of the disease as compared to late CPAP was associated with a 
significant reduction in subsequent use of invasive ventilation [9]. 
In the present study, CPAP-success rate was more in neonates in 
whom CPAP was started early (˂24 h, p=0.04) similar to the study 
by Shamil et al. (p=0.024).
Verder et al. published the first randomized controlled trial of 
surfactant instillation during CPAP showing that in infants with 
moderate-to-severe RDS, the need for subsequent mechanical 
ventilation could be reduced by half after a single dose of 
surfactant [10]. The effect was more pronounced if the surfactant 
treatment was given early in the course of the disease [10]. In our 
study, surfactant was given to 22 babies (9.05%), which was lower 
in comparison to the results observed by Koti et al. (55.3%) [1] 
and Sethi et al. (41.4%) [7].
In the present study, 48 (19.8%) out of 243 neonates were 
considered as CPAP failure, of which 20 neonates were ventilated 
and 28 neonates (11.5%) died. Mortality rate was more in preterm 
neonates with GA 28–31 weeks (8.64%, n=21) and neonates with 
birth weight ˂1500 g (8.23%, n=20). The high mortality rate in this 
study compared to the study by Koti et al. (10.7%) may be explained 
by inadequate usage of antenatal steroids, delay in initiation of 
CPAP, and lesser use of surfactant. Indian studies on CPAP have 
shown a failure rate of 25–50%. There were few limitations of this 
study. There was no monitoring protocol for the patients on CPAP.
CONCLUSION
The efficacy of CPAP in neonates with mild-to-moderate RDS in 
moderate preterm neonates is very well demonstrated despite the 
low usage of antenatal steroids, surfactant, and delayed initiation 
of CPAP. Extreme preterm neonates, VLBW neonates with severe 
RDS on chest X-ray are at risk of failure of CPAP.
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